Trial intelligence / Profile preview

Esomeprazole for NSAID-associated upper GI symptoms

NCT00241527Phase 3Completed

Sponsor
AstraZeneca
Start
Dec 2000
Primary completion
Sep 2002
Modality
Small Molecules
Countries
11
01

Overview

A Phase 3 trial of esomeprazole, sponsored by AstraZeneca. Started Dec 2000; status: completed.

02

Drugs

esomeprazole

Beyond the preview

Go deeper on NCT00241527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00241527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call